Breaking News

WellSpring Invests $3M, Enters IDT Australia Pact

Adds capabilities and equipment; will produce several products for U.S. market

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

WellSpring Pharma Services has completed a $3 million capital investment in new equipment and has entered a strategic partnership with IDT Australia Ltd. to manufacture drugs for the U.S. market.   The investment adds capabilities in smaller development-scale equipment, expanded manufacturing for specialized dosage forms, such as bilayer tablets, and improved support for high-potency compound manufacturing. New equipment includes: an Alexanderwerk Roller Compactor; an IMA Precisa capsule weigh...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters